Tech Company Financing Transactions
ReSync Bio Funding Round
Caffeinated Capital and private investors participated in a venture round for ReSync Bio. This venture round was announced on 9/25/2024.
Transaction Overview
Company Name
Announced On
9/25/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
private investors (Ramsey Homsany)
Proceeds Purpose
The company intends to use the funds to make key hires and commercialize their platform, which is now available for use by companies and academics.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
1770 Post St 281
San Francisco, CA 94115
USA
San Francisco, CA 94115
USA
Phone
Undisclosed
Website
Email Address
Overview
ReSync coordinates labs, data, and AI models on one platform. Stop wrangling with emails and spreadsheets -- find data and make decisions twice as fast.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mihir Trivedi
Browse more venture capital transactions:
Prev: 9/25/2024: Zing Health venture capital transaction
Next: 9/25/2024: Helaina venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs